Research

Mucosal immunisation of murine neonates using whole cell and acellular Pertussis vaccines


Reference:

Hale, C., Humphreys, I. R., Hussell, T., Bowe, F., Clare, S., Pickard, D., Preston, A., Del Giudice, G. and Dougan, G., 2004. Mucosal immunisation of murine neonates using whole cell and acellular Pertussis vaccines. Vaccine, 22 (27-28), pp. 3595-3602.

Related documents:

This repository does not currently have the full-text of this item.
You may be able to access a copy if URLs are provided below.

Official URL:

http://dx.doi.org/10.1016/j.vaccine.2004.03.039

Abstract

Groups of neonatal mice were immunised with different mucosal vaccines based on acellular (Pertactin antigen) or whole cell (inactivated Bordetella pertussis with Diphtheria and Tetanus toxoid) Pertussis vaccines, using Escherichia coli heat-labile enterotoxin (LT) as a mucosal adjuvant. Neonatal mice tolerated mucosal vaccination well and a significant cellular infiltrate was detected in the lungs of mice receiving mucosal vaccines compared to PBS controls. This infiltrate included B lymphocytes, gammadelta T cells and interferon-gamma producing T cells. Neonatal mice, in contrast to adult mice, responded poorly in terms of the production of serum antibody to Pertussis antigens delivered mucosally, although they were able to mount an anti-Tetanus response to those vaccines harbouring Tetanus toxoid and whole cell Pertussis antigen. Neonatal mice immunised with Pertactin or whole cell Pertussis antigen together with LT were protected against virulent B. pertussis challenge.

Details

Item Type Articles
CreatorsHale, C., Humphreys, I. R., Hussell, T., Bowe, F., Clare, S., Pickard, D., Preston, A., Del Giudice, G. and Dougan, G.
DOI10.1016/j.vaccine.2004.03.039
DepartmentsFaculty of Science > Biology & Biochemistry
RefereedYes
StatusPublished
ID Code32694

Export

Actions (login required)

View Item